Evidence map›Paper›PMID 42405542›Full record

ArticleInfection & chemotherapy2026

Survey on COVID-19 Vaccination among Pediatric Cancer Patients and Their Parents: A Single-Center Study from Korea.

Areum Shin, Doo Ri Kim, Hee Young Ju, Ji Won Lee, Keon Hee Yoo, Ki Woong Sung, Yae-Jean Kim

Abstract read
In one paragraph

Article in Infection & chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Areum ShinDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-3341-0447
Doo Ri KimDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5233-4043
Hee Young JuDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-6744-0412
Ji Won LeeDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-0084-1304
Keon Hee YooDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5980-7912
Ki Woong SungDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-5989-4772
Yae-Jean KimDepartment of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8367-3424

Funding

Samsung Medical Center SMX1230761
6 · The paper itself

Abstract

backgroundImmunocompromised children are a high-risk group for severe coronavirus disease 2019 (COVID-19). A nationwide study in Korea found that the average COVID-19 vaccination rate in high-risk children was higher than in the general pediatric population, whereas vaccination rates in pediatric cancer patients were lower. MATERIALS AND

methodsSurveys on COVID-19 vaccination among pediatric cancer patients and parents were conducted during the pandemic (July 1, 2022-July 31, 2022) and post-pandemic (December 26, 2023-January 5, 2024) periods. Vaccination rates of patients and their parents were compared with general population data. Factors associated with the vaccination status of patients were identified. Parental reasons for not vaccinating their children were also assessed.

resultsIn the first survey of 111 patients, the two-dose COVID-19 vaccination rate was 28.8%, lower than the rate in the general pediatric population, 40.7% (

conclusionConsidering the negative attitude toward the COVID-19 vaccine among parents of children with cancer, the government and healthcare professionals should endeavor to increase parental trust in this novel vaccine platform.

Indexed as

CancerChildCOVID-19ParentsVaccination

Identifiers

PMID42405542
PMCPMC13338688

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.